183 related articles for article (PubMed ID: 23238661)
1. Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.
Konrad K; Thon A; Fritsch M; Fröhlich-Reiterer E; Lilienthal E; Wudy SA; Holl RW;
Diabetes Care; 2013 Apr; 36(4):879-86. PubMed ID: 23238661
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis-related diabetes compared with type 1 and type 2 diabetes in adults.
Konrad K; Scheuing N; Badenhoop K; Borkenstein MH; Gohlke B; Schöfl C; Seufert J; Thon A; Holl RW
Diabetes Metab Res Rev; 2013 Oct; 29(7):568-75. PubMed ID: 23704008
[TBL] [Abstract][Full Text] [Related]
3. Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis-Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.
Konrad K; Kapellen T; Lilienthal E; Prinz N; Bauer M; Thon A; Rietschel E; Wiemann D; Holl RW;
Diabetes Care; 2016 Aug; 39(8):1338-44. PubMed ID: 27271187
[TBL] [Abstract][Full Text] [Related]
4. Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?
Scheuing N; Badenhoop K; Borkenstein M; Konrad K; Lilienthal E; Laubner K; Naeke A; Rami-Merhar B; Thon A; Wiemann D; Holl RW;
Pediatr Diabetes; 2015 Feb; 16(1):10-5. PubMed ID: 24984902
[TBL] [Abstract][Full Text] [Related]
5. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
Konrad K; Datz N; Engelsberger I; Grulich-Henn J; Hoertenhuber T; Knauth B; Meissner T; Wiegand S; Woelfle J; Holl RW;
Pediatr Diabetes; 2015 Nov; 16(7):529-37. PubMed ID: 25131985
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate intake and insulin requirement in children, adolescents and young adults with cystic fibrosis-related diabetes: A multicenter comparison to type 1 diabetes.
Scheuing N; Thon A; Konrad K; Bauer M; Karsten C; Meissner T; Seufert J; Schönau E; Schöfl C; Woelfle J; Holl RW;
Clin Nutr; 2015 Aug; 34(4):732-8. PubMed ID: 25245859
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of cystic fibrosis-related diabetes: Data from two different sources the European cystic fibrosis society patient registry and German/Austrian diabetes prospective follow-up registry.
Prinz N; Zolin A; Konrad K; Nährlich L; Laubner K; Olesen HV; Bauer M; Jung A; Frischer T; Holl RW;
Pediatr Diabetes; 2019 May; 20(3):255-262. PubMed ID: 30761696
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
Hameed S; Jaffé A; Verge CF
Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
[TBL] [Abstract][Full Text] [Related]
9. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents.
Rosenecker J; Eichler I; Bärmeier H; von der Hardt H
Pediatr Pulmonol; 2001 Nov; 32(5):351-5. PubMed ID: 11596159
[TBL] [Abstract][Full Text] [Related]
11. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
[TBL] [Abstract][Full Text] [Related]
12. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
[TBL] [Abstract][Full Text] [Related]
13. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Patients with Type 1 Diabetes and Additional Autoimmune Disease in the DPV Registry.
Prinz N; Tittel SR; Bachran R; Birnbacher R; Brückel J; Dunstheimer D; Haberland H; Hess M; Karges W; Oeverink R; Veigel A; Holl RW
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3381-e3389. PubMed ID: 34061946
[TBL] [Abstract][Full Text] [Related]
15. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
Moran A; Pekow P; Grover P; Zorn M; Slovis B; Pilewski J; Tullis E; Liou TG; Allen H;
Diabetes Care; 2009 Oct; 32(10):1783-8. PubMed ID: 19592632
[TBL] [Abstract][Full Text] [Related]
16. Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents.
Vollbach H; Auzanneau M; Reinehr T; Wiegand S; Schwab KO; Oeverink R; Froehlich-Reiterer E; Woelfle J; De Beaufort C; Kapellen T; Gohlke B; Holl RW
J Diabetes; 2021 Nov; 13(11):930-939. PubMed ID: 34184423
[TBL] [Abstract][Full Text] [Related]
17. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW
Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity of attention deficit hyperactivity disorder and type 1 diabetes in children and adolescents: Analysis based on the multicentre DPV registry.
Hilgard D; Konrad K; Meusers M; Bartus B; Otto KP; Lepler R; Schober E; Bollow E; Holl RW;
Pediatr Diabetes; 2017 Dec; 18(8):706-713. PubMed ID: 27523391
[TBL] [Abstract][Full Text] [Related]
19. Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study.
Tanner KT; Daniel RM; Bilton D; Simmonds NJ; Sharples LD; Keogh RH
Diabet Med; 2022 Nov; 39(11):e14958. PubMed ID: 36075586
[TBL] [Abstract][Full Text] [Related]
20. Impact of Maternal Country of Birth on Type-1-Diabetes Therapy and Outcome in 27,643 Children and Adolescents from the DPV Registry.
Scheuing N; Wiegand S; Bächle C; Fröhlich-Reiterer E; Hahn E; Icks A; Ludwig KH; Mönkemöller K; Razum O; Rosenbauer J; Holl RW;
PLoS One; 2015; 10(8):e0135178. PubMed ID: 26295472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
